Asset Management One
KITE

Asset Management One’s Kite Pharma, Inc. KITE Stock Holding History

Asset Management One’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,575
Closed -$470K – 1033
2017
Q2 		$470K Hold
4,575
– – ﹤0.01% 892
2017
Q1 		$358K Hold
4,575
– – ﹤0.01% 912
2016
Q4 		$207K Sell
4,575
-5,006
-52% -$246K ﹤0.01% 913
2016
Q3 		$536K Buy
9,581
+3,902
+69% +$217K 0.01% 1024
2016
Q2 		$288K Buy
5,679
+1,940
+52% +$95.3K ﹤0.01% 1161
2016
Q1 		$167K Buy
+3,739
New +$181K ﹤0.01% 1246

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Asset Management One's KITE Position: Q3 2017 in Review

Asset Management One sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 4,575 shares — an estimated $470K sold.

Asset Management One first reported a position in KITE in Q1 2016 and held it in 6 quarters. The position peaked at $536K in Q3 2016. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Asset Management One reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Asset Management One sold 4,575 Kite Pharma, Inc. shares in Q3 2017, an estimated $470K.
  • Asset Management One first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 6 quarters.
  • Asset Management One's Kite Pharma, Inc. position peaked at $536K in Q3 2016.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Asset Management One's 13F filing for Q3 2017, filed 14 Nov 2017.